Loading…

Development and Mechanism Studies of Cationic Chitosan-Modified Biodegradable PLGA Nanoparticles for Efficient siRNA Drug Delivery

Purpose In order to improve siRNA delivery for possible clinical applications, we developed biodegradable chitosan-modified poly(D,L-lactide-co-glycolide) (CHT-PLGA) nanoparticles with positive surface charge, high siRNA loading, high transfection efficiency and low toxicity. Methods CHT-PLGA nanopa...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceutical research 2010-07, Vol.27 (7), p.1285-1295
Main Authors: Yuan, Xudong, Shah, Bruhal A, Kotadia, Naimesh K, Li, Jian, Gu, Hua, Wu, Zhiqian
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c426t-6184835a464949abc9cf8d15177106af8234a7b0643d50a7411b9fea9ecd2b633
cites cdi_FETCH-LOGICAL-c426t-6184835a464949abc9cf8d15177106af8234a7b0643d50a7411b9fea9ecd2b633
container_end_page 1295
container_issue 7
container_start_page 1285
container_title Pharmaceutical research
container_volume 27
creator Yuan, Xudong
Shah, Bruhal A
Kotadia, Naimesh K
Li, Jian
Gu, Hua
Wu, Zhiqian
description Purpose In order to improve siRNA delivery for possible clinical applications, we developed biodegradable chitosan-modified poly(D,L-lactide-co-glycolide) (CHT-PLGA) nanoparticles with positive surface charge, high siRNA loading, high transfection efficiency and low toxicity. Methods CHT-PLGA nanoparticles were prepared, and siRNA was loaded by emulsion evaporation method with poly(vinyl alcohol) (PVA) as emulsifier. siRNA loading efficiency, particle size, and Zeta potential of nanoparticles were measured. Gel retardation and protection assays were conducted to determine the loading and binding of siRNA in the formulation. Cell transfection was performed to study in vitro siRNA silencing efficiency. XTT assay was used to evaluate the cytotoxicity. Results It was found that the nanoparticle diameter and positive Zeta potential increase as the chitosan coating concentration increases. CHT-PLGA nanoparticles showed excellent siRNA binding ability and effective protection of oligos from RNase degradation. siRNA-loaded nanoparticles were successfully delivered into the HEK 293 T cell line, and the silencing of green fluorescence protein (GFP) expression was observed using fluorescent microscopy and flow cytometry. In addition, the cytotoxicity assay revealed that CHT-PLGA nanoparticles had relatively low cytotoxicity. Conclusion This study suggests that biodegradable cationic CHT-PLGA nanoparticles possess great potential for efficient and safer siRNA delivery in future clinical applications.
doi_str_mv 10.1007/s11095-010-0103-0
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_744620988</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2057654151</sourcerecordid><originalsourceid>FETCH-LOGICAL-c426t-6184835a464949abc9cf8d15177106af8234a7b0643d50a7411b9fea9ecd2b633</originalsourceid><addsrcrecordid>eNp9kU9v1DAQxS0EokvhA3ABiwunwDh27Pi43W0L0rYgSiVuluM_W1dJvNhJpV77yUmUAhIHDqM5zO-9mdFD6DWBDwRAfMyEgKwKIDAXLeAJWpFK0EIC-_EUrUCUrKgFI0foRc63AFATyZ6joxIoSE74Cj1s3Z1r46Fz_YB1b_GFMze6D7nDV8Nog8s4erzRQ4h9MHhzE4aYdV9cRBt8cBafhGjdPmmrm9bhr7vzNb7UfTzoNATTTnIfEz71Ppgwr8jh2-Uab9O4x1vXhjuX7l-iZ1632b167Mfo-uz0--ZTsfty_nmz3hWGlXwoOKlZTSvNOJNM6sZI42tLKiIEAa59XVKmRQOcUVuBnr4mjfROS2ds2XBKj9H7xfeQ4s_R5UF1IRvXtrp3ccxKMMZLkHU9ke_-IW_jmPrpOEVFRUtWMZggskAmxZyT8-qQQqfTvSKg5njUEo-aopmLqlnz5tF4bDpn_yh-5zEB5QLkadTvXfq7-X-ubxeR11HpfQpZXV-VQCiQumKUV_QXgIqjIA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>375324540</pqid></control><display><type>article</type><title>Development and Mechanism Studies of Cationic Chitosan-Modified Biodegradable PLGA Nanoparticles for Efficient siRNA Drug Delivery</title><source>Springer Nature</source><creator>Yuan, Xudong ; Shah, Bruhal A ; Kotadia, Naimesh K ; Li, Jian ; Gu, Hua ; Wu, Zhiqian</creator><creatorcontrib>Yuan, Xudong ; Shah, Bruhal A ; Kotadia, Naimesh K ; Li, Jian ; Gu, Hua ; Wu, Zhiqian</creatorcontrib><description>Purpose In order to improve siRNA delivery for possible clinical applications, we developed biodegradable chitosan-modified poly(D,L-lactide-co-glycolide) (CHT-PLGA) nanoparticles with positive surface charge, high siRNA loading, high transfection efficiency and low toxicity. Methods CHT-PLGA nanoparticles were prepared, and siRNA was loaded by emulsion evaporation method with poly(vinyl alcohol) (PVA) as emulsifier. siRNA loading efficiency, particle size, and Zeta potential of nanoparticles were measured. Gel retardation and protection assays were conducted to determine the loading and binding of siRNA in the formulation. Cell transfection was performed to study in vitro siRNA silencing efficiency. XTT assay was used to evaluate the cytotoxicity. Results It was found that the nanoparticle diameter and positive Zeta potential increase as the chitosan coating concentration increases. CHT-PLGA nanoparticles showed excellent siRNA binding ability and effective protection of oligos from RNase degradation. siRNA-loaded nanoparticles were successfully delivered into the HEK 293 T cell line, and the silencing of green fluorescence protein (GFP) expression was observed using fluorescent microscopy and flow cytometry. In addition, the cytotoxicity assay revealed that CHT-PLGA nanoparticles had relatively low cytotoxicity. Conclusion This study suggests that biodegradable cationic CHT-PLGA nanoparticles possess great potential for efficient and safer siRNA delivery in future clinical applications.</description><identifier>ISSN: 0724-8741</identifier><identifier>EISSN: 1573-904X</identifier><identifier>DOI: 10.1007/s11095-010-0103-0</identifier><identifier>PMID: 20309616</identifier><language>eng</language><publisher>Boston: Boston : Springer US</publisher><subject>Biochemistry ; Biodegradation ; Biomedical and Life Sciences ; Biomedical Engineering and Bioengineering ; Biomedicine ; Cell Line ; Cell Survival - drug effects ; chitosan ; Chitosan - chemistry ; Drug Delivery Systems ; Humans ; Lactic Acid - administration &amp; dosage ; Lactic Acid - chemical synthesis ; Lactic Acid - chemistry ; Lactic Acid - pharmacology ; Medical Law ; Models, Biological ; Nanoparticles ; Nanoparticles - administration &amp; dosage ; Nanoparticles - chemistry ; nanotechnology ; Particle Size ; Pharmacology ; Pharmacology/Toxicology ; Pharmacy ; poly(D,L-lactide-co-glycolide) (PLGA) ; Polyglycolic Acid - administration &amp; dosage ; Polyglycolic Acid - chemical synthesis ; Polyglycolic Acid - chemistry ; Polyglycolic Acid - pharmacology ; Research Paper ; Ribonucleic acid ; RNA ; RNA, Small Interfering - administration &amp; dosage ; RNA, Small Interfering - chemistry ; RNA, Small Interfering - pharmacology ; siRNA delivery ; Toxicity</subject><ispartof>Pharmaceutical research, 2010-07, Vol.27 (7), p.1285-1295</ispartof><rights>Springer Science+Business Media, LLC 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c426t-6184835a464949abc9cf8d15177106af8234a7b0643d50a7411b9fea9ecd2b633</citedby><cites>FETCH-LOGICAL-c426t-6184835a464949abc9cf8d15177106af8234a7b0643d50a7411b9fea9ecd2b633</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27900,27901</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20309616$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yuan, Xudong</creatorcontrib><creatorcontrib>Shah, Bruhal A</creatorcontrib><creatorcontrib>Kotadia, Naimesh K</creatorcontrib><creatorcontrib>Li, Jian</creatorcontrib><creatorcontrib>Gu, Hua</creatorcontrib><creatorcontrib>Wu, Zhiqian</creatorcontrib><title>Development and Mechanism Studies of Cationic Chitosan-Modified Biodegradable PLGA Nanoparticles for Efficient siRNA Drug Delivery</title><title>Pharmaceutical research</title><addtitle>Pharm Res</addtitle><addtitle>Pharm Res</addtitle><description>Purpose In order to improve siRNA delivery for possible clinical applications, we developed biodegradable chitosan-modified poly(D,L-lactide-co-glycolide) (CHT-PLGA) nanoparticles with positive surface charge, high siRNA loading, high transfection efficiency and low toxicity. Methods CHT-PLGA nanoparticles were prepared, and siRNA was loaded by emulsion evaporation method with poly(vinyl alcohol) (PVA) as emulsifier. siRNA loading efficiency, particle size, and Zeta potential of nanoparticles were measured. Gel retardation and protection assays were conducted to determine the loading and binding of siRNA in the formulation. Cell transfection was performed to study in vitro siRNA silencing efficiency. XTT assay was used to evaluate the cytotoxicity. Results It was found that the nanoparticle diameter and positive Zeta potential increase as the chitosan coating concentration increases. CHT-PLGA nanoparticles showed excellent siRNA binding ability and effective protection of oligos from RNase degradation. siRNA-loaded nanoparticles were successfully delivered into the HEK 293 T cell line, and the silencing of green fluorescence protein (GFP) expression was observed using fluorescent microscopy and flow cytometry. In addition, the cytotoxicity assay revealed that CHT-PLGA nanoparticles had relatively low cytotoxicity. Conclusion This study suggests that biodegradable cationic CHT-PLGA nanoparticles possess great potential for efficient and safer siRNA delivery in future clinical applications.</description><subject>Biochemistry</subject><subject>Biodegradation</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedical Engineering and Bioengineering</subject><subject>Biomedicine</subject><subject>Cell Line</subject><subject>Cell Survival - drug effects</subject><subject>chitosan</subject><subject>Chitosan - chemistry</subject><subject>Drug Delivery Systems</subject><subject>Humans</subject><subject>Lactic Acid - administration &amp; dosage</subject><subject>Lactic Acid - chemical synthesis</subject><subject>Lactic Acid - chemistry</subject><subject>Lactic Acid - pharmacology</subject><subject>Medical Law</subject><subject>Models, Biological</subject><subject>Nanoparticles</subject><subject>Nanoparticles - administration &amp; dosage</subject><subject>Nanoparticles - chemistry</subject><subject>nanotechnology</subject><subject>Particle Size</subject><subject>Pharmacology</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacy</subject><subject>poly(D,L-lactide-co-glycolide) (PLGA)</subject><subject>Polyglycolic Acid - administration &amp; dosage</subject><subject>Polyglycolic Acid - chemical synthesis</subject><subject>Polyglycolic Acid - chemistry</subject><subject>Polyglycolic Acid - pharmacology</subject><subject>Research Paper</subject><subject>Ribonucleic acid</subject><subject>RNA</subject><subject>RNA, Small Interfering - administration &amp; dosage</subject><subject>RNA, Small Interfering - chemistry</subject><subject>RNA, Small Interfering - pharmacology</subject><subject>siRNA delivery</subject><subject>Toxicity</subject><issn>0724-8741</issn><issn>1573-904X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNp9kU9v1DAQxS0EokvhA3ABiwunwDh27Pi43W0L0rYgSiVuluM_W1dJvNhJpV77yUmUAhIHDqM5zO-9mdFD6DWBDwRAfMyEgKwKIDAXLeAJWpFK0EIC-_EUrUCUrKgFI0foRc63AFATyZ6joxIoSE74Cj1s3Z1r46Fz_YB1b_GFMze6D7nDV8Nog8s4erzRQ4h9MHhzE4aYdV9cRBt8cBafhGjdPmmrm9bhr7vzNb7UfTzoNATTTnIfEz71Ppgwr8jh2-Uab9O4x1vXhjuX7l-iZ1632b167Mfo-uz0--ZTsfty_nmz3hWGlXwoOKlZTSvNOJNM6sZI42tLKiIEAa59XVKmRQOcUVuBnr4mjfROS2ds2XBKj9H7xfeQ4s_R5UF1IRvXtrp3ccxKMMZLkHU9ke_-IW_jmPrpOEVFRUtWMZggskAmxZyT8-qQQqfTvSKg5njUEo-aopmLqlnz5tF4bDpn_yh-5zEB5QLkadTvXfq7-X-ubxeR11HpfQpZXV-VQCiQumKUV_QXgIqjIA</recordid><startdate>20100701</startdate><enddate>20100701</enddate><creator>Yuan, Xudong</creator><creator>Shah, Bruhal A</creator><creator>Kotadia, Naimesh K</creator><creator>Li, Jian</creator><creator>Gu, Hua</creator><creator>Wu, Zhiqian</creator><general>Boston : Springer US</general><general>Springer US</general><general>Springer Nature B.V</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7QO</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20100701</creationdate><title>Development and Mechanism Studies of Cationic Chitosan-Modified Biodegradable PLGA Nanoparticles for Efficient siRNA Drug Delivery</title><author>Yuan, Xudong ; Shah, Bruhal A ; Kotadia, Naimesh K ; Li, Jian ; Gu, Hua ; Wu, Zhiqian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c426t-6184835a464949abc9cf8d15177106af8234a7b0643d50a7411b9fea9ecd2b633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Biochemistry</topic><topic>Biodegradation</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedical Engineering and Bioengineering</topic><topic>Biomedicine</topic><topic>Cell Line</topic><topic>Cell Survival - drug effects</topic><topic>chitosan</topic><topic>Chitosan - chemistry</topic><topic>Drug Delivery Systems</topic><topic>Humans</topic><topic>Lactic Acid - administration &amp; dosage</topic><topic>Lactic Acid - chemical synthesis</topic><topic>Lactic Acid - chemistry</topic><topic>Lactic Acid - pharmacology</topic><topic>Medical Law</topic><topic>Models, Biological</topic><topic>Nanoparticles</topic><topic>Nanoparticles - administration &amp; dosage</topic><topic>Nanoparticles - chemistry</topic><topic>nanotechnology</topic><topic>Particle Size</topic><topic>Pharmacology</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacy</topic><topic>poly(D,L-lactide-co-glycolide) (PLGA)</topic><topic>Polyglycolic Acid - administration &amp; dosage</topic><topic>Polyglycolic Acid - chemical synthesis</topic><topic>Polyglycolic Acid - chemistry</topic><topic>Polyglycolic Acid - pharmacology</topic><topic>Research Paper</topic><topic>Ribonucleic acid</topic><topic>RNA</topic><topic>RNA, Small Interfering - administration &amp; dosage</topic><topic>RNA, Small Interfering - chemistry</topic><topic>RNA, Small Interfering - pharmacology</topic><topic>siRNA delivery</topic><topic>Toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yuan, Xudong</creatorcontrib><creatorcontrib>Shah, Bruhal A</creatorcontrib><creatorcontrib>Kotadia, Naimesh K</creatorcontrib><creatorcontrib>Li, Jian</creatorcontrib><creatorcontrib>Gu, Hua</creatorcontrib><creatorcontrib>Wu, Zhiqian</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Biotechnology Research Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Pharmaceutical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yuan, Xudong</au><au>Shah, Bruhal A</au><au>Kotadia, Naimesh K</au><au>Li, Jian</au><au>Gu, Hua</au><au>Wu, Zhiqian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development and Mechanism Studies of Cationic Chitosan-Modified Biodegradable PLGA Nanoparticles for Efficient siRNA Drug Delivery</atitle><jtitle>Pharmaceutical research</jtitle><stitle>Pharm Res</stitle><addtitle>Pharm Res</addtitle><date>2010-07-01</date><risdate>2010</risdate><volume>27</volume><issue>7</issue><spage>1285</spage><epage>1295</epage><pages>1285-1295</pages><issn>0724-8741</issn><eissn>1573-904X</eissn><abstract>Purpose In order to improve siRNA delivery for possible clinical applications, we developed biodegradable chitosan-modified poly(D,L-lactide-co-glycolide) (CHT-PLGA) nanoparticles with positive surface charge, high siRNA loading, high transfection efficiency and low toxicity. Methods CHT-PLGA nanoparticles were prepared, and siRNA was loaded by emulsion evaporation method with poly(vinyl alcohol) (PVA) as emulsifier. siRNA loading efficiency, particle size, and Zeta potential of nanoparticles were measured. Gel retardation and protection assays were conducted to determine the loading and binding of siRNA in the formulation. Cell transfection was performed to study in vitro siRNA silencing efficiency. XTT assay was used to evaluate the cytotoxicity. Results It was found that the nanoparticle diameter and positive Zeta potential increase as the chitosan coating concentration increases. CHT-PLGA nanoparticles showed excellent siRNA binding ability and effective protection of oligos from RNase degradation. siRNA-loaded nanoparticles were successfully delivered into the HEK 293 T cell line, and the silencing of green fluorescence protein (GFP) expression was observed using fluorescent microscopy and flow cytometry. In addition, the cytotoxicity assay revealed that CHT-PLGA nanoparticles had relatively low cytotoxicity. Conclusion This study suggests that biodegradable cationic CHT-PLGA nanoparticles possess great potential for efficient and safer siRNA delivery in future clinical applications.</abstract><cop>Boston</cop><pub>Boston : Springer US</pub><pmid>20309616</pmid><doi>10.1007/s11095-010-0103-0</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0724-8741
ispartof Pharmaceutical research, 2010-07, Vol.27 (7), p.1285-1295
issn 0724-8741
1573-904X
language eng
recordid cdi_proquest_miscellaneous_744620988
source Springer Nature
subjects Biochemistry
Biodegradation
Biomedical and Life Sciences
Biomedical Engineering and Bioengineering
Biomedicine
Cell Line
Cell Survival - drug effects
chitosan
Chitosan - chemistry
Drug Delivery Systems
Humans
Lactic Acid - administration & dosage
Lactic Acid - chemical synthesis
Lactic Acid - chemistry
Lactic Acid - pharmacology
Medical Law
Models, Biological
Nanoparticles
Nanoparticles - administration & dosage
Nanoparticles - chemistry
nanotechnology
Particle Size
Pharmacology
Pharmacology/Toxicology
Pharmacy
poly(D,L-lactide-co-glycolide) (PLGA)
Polyglycolic Acid - administration & dosage
Polyglycolic Acid - chemical synthesis
Polyglycolic Acid - chemistry
Polyglycolic Acid - pharmacology
Research Paper
Ribonucleic acid
RNA
RNA, Small Interfering - administration & dosage
RNA, Small Interfering - chemistry
RNA, Small Interfering - pharmacology
siRNA delivery
Toxicity
title Development and Mechanism Studies of Cationic Chitosan-Modified Biodegradable PLGA Nanoparticles for Efficient siRNA Drug Delivery
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-24T10%3A18%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20and%20Mechanism%20Studies%20of%20Cationic%20Chitosan-Modified%20Biodegradable%20PLGA%20Nanoparticles%20for%20Efficient%20siRNA%20Drug%20Delivery&rft.jtitle=Pharmaceutical%20research&rft.au=Yuan,%20Xudong&rft.date=2010-07-01&rft.volume=27&rft.issue=7&rft.spage=1285&rft.epage=1295&rft.pages=1285-1295&rft.issn=0724-8741&rft.eissn=1573-904X&rft_id=info:doi/10.1007/s11095-010-0103-0&rft_dat=%3Cproquest_cross%3E2057654151%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c426t-6184835a464949abc9cf8d15177106af8234a7b0643d50a7411b9fea9ecd2b633%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=375324540&rft_id=info:pmid/20309616&rfr_iscdi=true